Showing results (61-70 of 74) with videos related to
Sort By:
Pageof 8
Cancer Gene Therapy|June 8, 1999
Gene therapy study of cytokine-transfected xenogeneic cells (Vero-interleukin-2) in patients with metastatic solid tumorsC Rochlitz, P Jantscheff, G Bongartz, et al.Immunity|October 6, 2000
Soluble CD86 is a costimulatory molecule for human T lymphocytesP Jeannin, G Magistrelli, J P Aubry, et al.The Journal of Clinical Investigation|March 15, 1997
Fas ligand expression by astrocytoma in vivo: maintaining immune privilege in the brain?P Saas, P R Walker, M Hahne, et al.Advances in Experimental Medicine and Biology|February 23, 1999
Gene therapy with cytokine-transfected xenogeneic cells in metastatic tumorsC F Rochlitz, P Jantscheff, G Bongartz, et al.The Journal of Pathology|March 9, 2006
Expression and localization of VEGF-C and VEGFR-3 in glioblastomas and haemangioblastomasB Jenny, J A Harrison, D Baetens, et al.British Journal of Cancer|May 3, 2014
Phase I study of sorafenib combined with radiation therapy and temozolomide as first-line treatment of high-grade gliomaA F Hottinger, A Ben Aissa, V Espeli, et al.British Journal of Cancer|January 10, 2018
Phase I study of sorafenib combined with radiation therapy and temozolomide as first-line treatment of high-grade gliomaA F Hottinger, A Ben Aissa, V Espeli, et al.Cancer Research|August 2, 2001
Heterogeneous T-cell response to MAGE-A10(254-262): high avidity-specific cytolytic T lymphocytes show superior antitumor activityV Dutoit, V Rubio-Godoy, P Y Dietrich, et al.Journal of Neuro-Oncology|October 14, 2015
Patterns of care in recurrent glioblastoma in Switzerland: a multicentre national approach based on diagnostic nodesT Hundsberger, A F Hottinger, U Roelcke, et al.European Cytokine Network|September 1, 1996
Serum interleukin-12 levels in patients undergoing allogeneic or autologous bone marrow transplantationB Bonnotte, A M Burdiles, J Chehimi, et al.Pageof 8